Day 1 - Thursday, 19 September 2019

 08:45 Opening of the workshop 
 Session 1: Epidemiology of HIV and hepatitis in the CEE countries and access to care
 09:00Epidemiology of viral hepatitis infection and treatment in Europe
Speaker to be confirmed

Epidemiology of HIV infection and treatment in Europe
Teymur Noori, ECDC, Stockholm, Sweden

 10:00Where we are in terms of providing access and where we should go
Speaker to be confirmed
 10:30 Coffee break and poster viewing 
 Session 2: Access to care

EECA: are we lagging behind?  
Sergey Golovin, ITPCru, St. Petersburg, Russia


Access to quality assured  (WHO prequalified) generic medicines in the region
Liudmyla Maistat, Medicines Patent Pool, Geneva, Switzerland


Dedes, Nicos 2019
Access to key populations
Nikos Dedes, EATG, Greece

 11:30Roundtable discussion 
 Session 3: HIV and hepatitis coinfection

Management of HIV/HCV in young women
Vadim Rassokhin, MD, 1st St. Petersburg State Medical University "Acad. I.P. Pavlov", St. Petersburg, Russia

 12:00 Abstract-driven presentations 
 12:30Group picture and lunch 
 13:30Industry-sponsored symposium 
 Session 4: PrEP

PrEP and STI testing in CEE: What are the barriers, what works?
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Sczecin, Poland

 15:20Panel discussion 
 15:30 Coffee break and poster viewing 
 16:00Industry-sponsored symposium 
 Session 5: Linkage to care and management of treatment failure in HIV

Switching to second-line HIV therapy
Pavel Khaykin, MD, MainFachArzt, Frankfurt, Germany


Raben, DortheIntegrated testing for HIV, hepatitis, and STIs
Dorthe Raben, MSc, CHIP, Copenhagen, Denmark

 18:15End of day 1
Welcome reception and poster viewing
 19:30 Group dinner

Day 2 - Friday, 20 September 2019

 Session 6: HIV and Tuberculosis coinfection
 9:00Management TB  and HIV infection
Daria Podlekareva, MD 
University of Copenhagen, Copenhagen, Denmark

The challenging TB case: clinical, virological and pharmacological considerations
Jonathan Schapiro, MD, Sheba Medical Centre, Tel Aviv, Israel

 10:00 Abstract-driven presentations 
 10:30Coffee break and poster viewing 
 Session 7
 11:00 Abstract - driven presentations 
 12:00 Lunch 
 13:00 Industry-sponsored symposium 
 Session 8: Hot topics in HIV and Hepatitis
 14:00Schwarze-Zander, CarolynneVaccinations for HIV patients: which vaccinations when and how?
Carolynne Schwarze-Zander, PhD, University of Bonn, Bonn, Germany

Treatment of Hepatitis B: What are the remaining challenges?
Olga Golubovska, MD, PhD, Bogomolets National Medical University, Kyiv, Ukraine


Ligita JančorienėHIV/HCV coinfection: Influence on risk for cancer and cardiovascular events, and impact of successful HCV cure 
Ligita Jancoriene, MD, PhD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

 15:15 0Hepatitis E in HIV-infected patients
Speaker to be confirmed
 15:40 End of conference